Global TradFi & Macroeconomics

Focus on price action and volatility across stocks, bonds, forex, commodities, and major indices. Analyze macro indicators like interest rates, inflation, employment, and policy expectations to decode global liquidity shifts, risk sentiment, and cross-market correlations.
All
Stocks
Metals
Indices
Forex
Commodities

CNEX Market Sentiment Index Falls to 50 on November 5, Down 1 Point

According to Jin10 Futures, the CNEX market-wide sentiment index fell to 50 as of 4 p.m. on November 5, down 1 point from 2:30 p.m. Large banks, mid-sized banks, and non-bank institutions reported sentiment indices of 47, 50, and 52 respectively, each declining 1 point. The index ranges from 0 to 10
GateNews·11-05 08:06
CNEX Market Sentiment Index Falls to 50 on November 5, Down 1 Point

China and Oman Deepen Trade and Investment Cooperation, November 5

According to China's Ministry of Commerce, on November 5, China is Oman's largest trading partner and primary crude oil export destination, while Oman ranks as China's fourth-largest trade partner among Arab nations. The two countries have expanded bilateral investment and advanced infrastructure co
GateNews·11-05 07:53
China and Oman Deepen Trade and Investment Cooperation, November 5

Microsoft Declines Nscale Texas Data Center Expansion Worth Billions

UK AI cloud provider Nscale, preparing for an initial public offering at a $35 billion valuation, faces a major setback after Microsoft declined to exercise expansion options on a Texas data center capacity lease. Nscale clarified this week that the unexercised option involves approximately 500MW of
MSFT-2.15%
NVDA-5.47%
GateMacroTradfiHub·11-05 07:50
Microsoft Declines Nscale Texas Data Center Expansion Worth Billions

Novo Nordisk Raises 2026 Guidance on Strong Oral Wegovy Sales

Novo Nordisk (NVO.US) reported third-quarter earnings on November 4 that exceeded analyst expectations, driven by strong sales of oral weight-loss drug Wegovy, prompting the Danish pharmaceutical giant to raise its full-year outlook for the third time this year. The company's adjusted Q3 revenue
NVO-1.69%
GateMacroTradfiHub·11-05 07:49
Novo Nordisk Raises 2026 Guidance on Strong Oral Wegovy Sales

Insulet Q3 Revenue Hits $842M, Up 19% YoY; Authorizes $1B Buyback

Insulet, an insulin pump manufacturer, reported third-quarter revenue of $842 million, up 19.2% year-over-year, with adjusted earnings per share of $1.99, a 60% increase from the prior-year period. The company attributed the growth to a customer base expansion exceeding 20% annually and the
GateMacroTradfiHub·11-05 07:49
Insulet Q3 Revenue Hits $842M, Up 19% YoY; Authorizes $1B Buyback